Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. 

Biotechnology

Consumer

Azitra

Francisco Salva

Dorival Martins

Roger Leger

Peter F.

Alexander P. Tikhonov

Edward B. Punzalan

Travis Whitfill

Leadership Team

Technology Development

Teams at Azitra

Leadership Team

Technology Development